Mobile
Recherche simple
Recherche avancée
Recherche multicritère
Qui sommes-nous ?
Connexion
Inscription
French
English
Kusajili – Centralise les essais cliniques mondiaux
Votre recherche
Pays: Korea, Republic of,Morocco,Belgium,Estonia,France,Turkey,India,Taiwan, Province of China
nct
MAJ Il y a 5 ans
Efficacy and Safety of SR58611A co-Administered With Escitalopram in Adults With Major Depressive Disorder
The primary objective of the study is to compare, after 8 weeks, the efficacy of SR58611A vs. placebo in patients with Major Depressive Disorder who are on concomitant treatment with escitalopram. The secondary objective of this study is to document clinical safety and tolerability of SR58611A in association with escitalopram.
Pays
Belgium
,
Estonia
,
Finland
,
France
,
Germany
,
Greece
,
India
,
Korea, Republic of
,
Malaysia
,
Morocco
,
Taiwan, Province of China
,
Tunisia
,
Turkey
,
Organes
Aucun
Spécialités
Aucun
Essai clos aux inclusions
Plus d'informations
1